Researchers are targeting dormant tumour cells that might explain why some cancers reappear long after successful treatment.
Formerly Somite AI, the rebranded company aims to broaden the regenerative medicine landscape by building AI models that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback